Zydus Lifesciences Ltd has released its audited financial results for the quarter and year ending March 31, 2025, showing a Q4 revenue of Rs. 65,279 million, a net profit of Rs. 13,905 million, and a full-year revenue of Rs. 2,32,415 million, both reflecting year-over-year increases, along with a 1100% dividend recommendation.